Discover how newer therapies for acute lymphoblastic leukemia (ALL) offer patients hope. Learn about the benefits of targeted treatments like Besponsa, glembatumumab and Blincyto.

Key Points:

- Reduced side effects compared to traditional chemotherapy
- Improved tolerability for older patients
- Targeted therapy for cancer cells

Watch the full interview with Dr. Hannah Levavi to better understand these innovative treatments and their potential impact on patient outcomes.

#acutelymphoblasticleukemia #ALL #cancer #cancertreatment #newtreatments #cancerresearch #cancerawareness #health #healthcare #medicine #oncology #hematology

View more at [ Ссылка ]

Or visit out socials!

[ Ссылка ]
[ Ссылка ]
[ Ссылка ]
[ Ссылка ]

CURE® has become the largest consumer magazine in the United States focused entirely on cancer. With a total circulation of 285,000, individual subscribers account for over 140,000 of that figure, with the remainder including cancer centers and advocacy groups around the country. CURE®’s time-tested approach combines science, humanity and technology to make cancer understandable for patients and their caregivers.

Image Credit: Adobe Stock

свернуть